Track the Sernova Biotherapeutics Inc. stock price and the full insider trade history of the company, a listed equity based in Canada. Shares are quoted on the CA market, under the supervision of SEDI. Operating in the Health Care sector, Sernova Biotherapeutics Inc. has logged 12 insider filings. Market capitalisation: €41.5m. The latest transaction was reported on 28 August 2026 (16 - Acquisition or disposition under a prospectus exemption). Among the most active insiders: Sangha, Steven. All data is accessible without an account.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Sernova Biotherapeutics Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias celulares para enfermedades crónicas. Cotiza en el XTSE.